Clinical Trials

945 enrolled 19 charts

Melanoma

NCT03551626 2025-04-29

COMBI-APlus

552 enrolled 12 charts

Fever, Melanoma

NCT02388906 2025-04-24

CheckMate 238

906 enrolled 16 charts 1 FDA

Melanoma

NCT00472459 2025-04-18

Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer

82 enrolled 20 charts

Bowen's Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Warts, Keratosis, Actinic

NCT03635983 2025-04-01

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

783 enrolled 24 charts

Melanoma

NCT02549352 2025-03-13

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

391 enrolled 16 charts

Keratosis, Actinic

NCT03115476 2025-03-11

A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp

563 enrolled 15 charts

Carcinoma, Squamous Cell, Keratosis, Actinic

NCT01541553 2025-03-10

A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp

367 enrolled 10 charts

Keratosis, Actinic

NCT02361216 2025-03-10

Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest

729 enrolled 14 charts

Keratosis, Actinic

NCT02547233 2025-03-10

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up

437 enrolled 15 charts

Keratosis, Actinic

NCT02547363 2025-03-10

Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up

373 enrolled 13 charts

Keratosis, Actinic

NCT02549339 2025-03-10

Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up

383 enrolled 16 charts

Keratosis, Actinic

NCT01787383 2025-02-24

A Simultaneous Treatment Regimen Compared to a Sequential Treatment Regimen With Ingenol Mebutate Gel 0.015% and 0.05% of Two Areas With Actinic Keratosis on Face/Scalp and Trunk/Extremities

200 enrolled 16 charts

Keratosis, Actinic

NCT01748448 2025-02-17

ViDMe

436 enrolled 16 charts

Phase 3 Active not recruiting

Melanoma, Cutaneous Malignant

NCT03553836 2024-11-29

KEYNOTE-716

976 enrolled 15 charts 1 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT01871727 2024-11-13

A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma

112 enrolled 40 charts

DermatologicLymphoid

Lymphoma, T-Cell, Cutaneous

NCT04308395 2024-09-24

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

108 enrolled 12 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT00472043 2024-08-06

PDT With Metvix 160 mg/g Cream Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Call Carcinoma

66 enrolled 15 charts

Carcinoma, Basal Cell

NCT00472108 2024-08-05

Photodynamic Therapy (PDT) With Metvix Cream 160 mg/g Versus PDT With Placebo Cream in Participants With Primary Nodular Basal Cell Carcinoma

65 enrolled 15 charts

Carcinoma, Basal Cell

NCT03233828 2024-07-24

IL-2

1 enrolled 3 charts

Melanoma

NCT03703310 2024-07-03

Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)

174 enrolled 23 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT01728805 2024-04-25

Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL

372 enrolled 14 charts 1 FDA

DermatologicLymphoid

Sezary Syndrome, Lymphoma, T-Cell, Cutaneous

NCT05279131 2024-01-23

A Study to Evaluate the Safety and Tolerability of Tirbanibulin Ointment 1% in Adult Participants With Actinic Keratosis

105 enrolled 26 charts

Keratosis, Actinic

NCT04269395 2023-10-10

A Study to Assess Recurrence of Actinic Keratosis in Participants Treated With Methyl Aminolevulinate Hydrochloride Cream or Vehicle Cream Who Achieved Complete Response to Treated Lesions in Earlier Study

125 enrolled 8 charts

Keratosis, Actinic

NCT01682083 2023-08-30

COMBI-AD

870 enrolled 13 charts 1 FDA

Melanoma, Neoplasms

NCT01966120 2023-07-28

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

87 enrolled 21 charts

Keratosis, Actinic

NCT00304239 2023-07-03

Metvix PDT Versus Vehicle PDT With Aktilite CL128 Lamp in Patients With Actinic Keratosis on the Face and Scalp

131 enrolled 9 charts

Keratosis, Actinic

NCT04410445 2023-04-21

PIVOT-12

765 enrolled 13 charts

Melanoma, Skin Neoplasms

NCT01359956 2023-04-11

SICOG 0109

269 enrolled 12 charts

Melanoma

NCT03294330 2023-01-12

SPYX

35 enrolled 9 charts

BreastDermatologic

Breast Neoplasms, Melanoma

NCT00473343 2023-01-05

Metvix PDT in Participant With "High Risk" Basal Cell Carcinoma

102 enrolled 13 charts

Carcinoma, Basal Cell

NCT03445533 2022-11-08

A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma

481 enrolled 22 charts

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT02144077 2022-11-03

Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy

281 enrolled 16 charts

Carcinoma, Basal Cell

NCT01721772 2022-07-12

CheckMate 066

418 enrolled 16 charts